JIA Uveitis Control Improved With Adalimumab + MTX

by Medscape • 2017/05/02 • 0 Comments

Adding adalimumab to MTX for treatment-resistant uveitis was associated with juvenile idiopathic arthritis improved disease control and enabled many patients to reduce or stop topical glucocorticoids.
Medscape Medical News

Full Story →

← Ocular Therapeutix™ to Present Data on Anterior and Posterior Segment Drug Product Candidates at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

KAMRA® Corneal Inlay Utilizes Camera Technology to Sharpen and Clear Blurry Near Vision for Patients →

Post navigation